scholarly journals On-line breath analysis of volatile organic compounds as a method for colorectal cancer detection.

2012 ◽  
Vol 30 (15_suppl) ◽  
pp. 1570-1570
Author(s):  
Francisco Zambrana Tevar ◽  
Ana Herrero ◽  
Guillermo Vidal-de-Miguel ◽  
Gonzalo Bailador ◽  
Ernesto Criado ◽  
...  

1570 Background: Analysis of exhaled volatile organic compounds (VOCs) in breath is an emerging approach for cancer diagnosis, but little is known about its potential use as a biomarker for colorectal cancer (CRC). We investigated whether a combination of VOCs could distinct CRC patients from healthy volunteers. Methods: In a pilot study, we prospectively analyzed breath exhalations of 38 CRC patient and 43 healthy controls all scheduled for colonoscopy, older than 50 in the average-risk category. The samples were ionized and analyzed using a Secondary ElectroSpray Ionization (SESI) coupled with a Time-of-Flight Mass Spectrometer (SESI-MS). After a minimum of 2 hours fasting, volunteers deeply exhaled into the system. Each test requires three soft exhalations and takes less than ten minutes. No breath condensate or collection are required and VOCs masses are detected in real time, also allowing for a spirometric profile to be analyzed along with the VOCs. A new sampling system precludes ambient air from entering the system, so background contamination is reduced by an overall factor of ten. Potential confounding variables from the patient or the environment that could interfere with results were analyzed. Results: 255 VOCs, with masses ranging from 30 to 431 Dalton have been identified in the exhaled breath. Using a classification technique based on the ROC curve for each VOC, a set of 9 biomarkers discriminating the presence of CRC from healthy volunteers was obtained, showing an average recognition rate of 81.94%, a sensitivity of 87.04% and specificity of 76.85%. Conclusions: A combination of cualitative and cuantitative analysis of VOCs in the exhaled breath could be a powerful diagnostic tool for average-risk CRC population. These results should be taken with precaution, as many endogenous or exogenous contaminants could interfere as confounding variables. On-line analysis with SESI-MS is less time-consuming and doesn’t need sample preparation. We are recruiting in a new pilot study including breath cleaning procedures and spirometric analysis incorporated into the postprocessing algorithms, to better control for confounding variables.

2002 ◽  
Vol 36 ◽  
pp. 22
Author(s):  
Gunda Millonig ◽  
Siegfried Praun ◽  
Guenther Eibl ◽  
Johannes Villinger ◽  
Wolfgang Vogel

2015 ◽  
Vol 9 (9) ◽  
pp. 731-737 ◽  
Author(s):  
Lucy C. Hicks ◽  
Juzheng Huang ◽  
Sacheen Kumar ◽  
Sam T. Powles ◽  
Timothy R. Orchard ◽  
...  

2021 ◽  
Vol 11 ◽  
Author(s):  
Lijuan Xiang ◽  
Sihan Wu ◽  
Qingling Hua ◽  
Chuyang Bao ◽  
Hu Liu

IntroductionHuman exhaled volatile organic compounds (VOCs) are being extensively studied for the purposes of noninvasive cancer diagnoses. This article was primarily to assess the feasibility of utilizing exhaled VOCs analysis for gastrointestinal cancer (GIC) diagnosis.MethodsPRISMA-based system searches were conducted for related studies of exhaled VOCs in GIC diagnosis based on predetermined criteria. Relevant articles on colorectal cancer and gastroesophageal cancer were summarized, and meta analysis was performed on articles providing sensitivity and specificity data.ResultsFrom 2,227 articles, 14 were found to meet inclusion criteria, six of which were on colorectal cancer (CRC) and eight on Gastroesophageal cancer(GEC). Five articles could provide specific data of sensitivity and specificity in GEC, which were used for meta-analysis. The pooled sensitivity, specificity, diagnostic odds ratio (DOR), and area under the curve (AUC) were calculated based on the combination of these data, and were 85.0% [95% confidence interval (CI): 79.0%–90.0%], 89.0% (95%CI: 86.0%–91.0%), 41.30 (21.56–79.10), and 0.93, respectively.ConclusionVOCs can distinguish gastrointestinal cancers from other gastrointestinal diseases, opening up a new avenue for the diagnosis and identification of gastrointestinal cancers, and the analysis of VOCs in exhaled breath has potential clinical application in screening. VOCs are promising tumor biomarkers for GIC diagnosis. Furthermore, limitations like the heterogeneity of diagnostic VOCs between studies should be minded.


2019 ◽  
Vol 13 (2) ◽  
pp. 026006 ◽  
Author(s):  
Agne Krilaviciute ◽  
Marcis Leja ◽  
Annette Kopp-Schneider ◽  
Orna Barash ◽  
Salam Khatib ◽  
...  

2020 ◽  
Vol 62 (2) ◽  
pp. 212-221 ◽  
Author(s):  
Lyudmila V. Bel'skaya ◽  
Elena A. Sarf ◽  
Sergey P. Shalygin ◽  
Tatyana V. Postnova ◽  
Victor K. Kosenok

Sign in / Sign up

Export Citation Format

Share Document